Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years

Date: 
7 Nov 2017
Source: 
JAMA Internal Medicine
Audience: 
Patients and public
Type of resource: 
Research

In cancer models, warfarin inhibits AXL receptor tyrosine kinase–dependent tumorigenesis and enhances antitumor immune responses at doses not reaching anticoagulation levels. This study investigates the association between warfarin use and cancer incidence in a large, unselected population-based cohort.

 

Click here to read the Research in full